1. Prognostic value of long noncoding RNA urothelial carcinoma-associated 1 in esophageal carcinoma
    Hong Zhang et al, 2021 CrossRef
  2. Long noncoding RNASEH1‐AS1 exacerbates the progression of non‐small cell lung cancer by acting as a ceRNA to regulate microRNA‐516a‐5p/FOXK1 and thereby activating the Wnt/β‐catenin signaling pathway
    Chan Zhang et al, 2022, Cancer Medicine CrossRef
  3. The miRNA-21-5p Payload in Exosomes from M2 Macrophages Drives Tumor Cell Aggression via PTEN/Akt Signaling in Renal Cell Carcinoma
    Zhicheng Zhang et al, 2022, IJMS CrossRef
  4. Diagnostic significance of miRNAs as potential biomarkers for human renal cell carcinoma: a systematic review and meta-analysis
    Yiwei Gu et al, 2022, Expert Review of Anticancer Therapy CrossRef
  5. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
    Maliheh Entezari et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  6. The Novel Regulatory Role of the lncRNA–miRNA–mRNA Axis in Chronic Inflammatory Airway Diseases
    Xin Qiao et al, 2022, Front. Mol. Biosci. CrossRef
  7. lncRNA NBAT1 Inhibits Cell Metastasis and Promotes Apoptosis in Endometrial Cancer by Sponging miR-21-5p to Regulate PTEN
    Chunhua Tian et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
  8. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents
    Mehrdad Hashemi et al, 2022, Pharmacological Research CrossRef
  9. A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers
    Jie Xu et al, 2022, Front. Cell Dev. Biol. CrossRef
  10. Long Non-Coding RNA MEG3 in Metal Carcinogenesis
    Zhuo Zhang et al, 2023, Toxics CrossRef
  11. Long Noncoding RNA TFAP2A-AS1 Exerts Promotive Effects in Non-Small Cell Lung Cancer Progression Via Controlling the microRNA-548a-3p/CDK4 axis as a Competitive Endogenous RNA
    YANG ZHANG et al, 2021 CrossRef
  12. The role of selected non-coding RNAs in the biology of non-small cell lung cancer
    Kajetan Kiełbowski et al, 2023, Advances in Medical Sciences CrossRef
  13. Potential mechanism of Taohong Siwu Decoction in uterine fibroid treatment based on integrated strategy of network pharmacology and experimental verification
    Shasha Shi et al, 2023, Chin Med CrossRef
  14. Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer
    Waleed Hassan Almalki, 2023, Pathology - Research and Practice CrossRef
  15. Comprehensive analysis of circulating cell-free RNAs in blood for diagnosing non-small cell lung cancer
    Yulin Liu et al, 2023, Computational and Structural Biotechnology Journal CrossRef
  16. Roles of noncoding RNAs in chronic obstructive pulmonary disease
    Xin Qiao et al, 2023 CrossRef
  17. Research Progress on the Relationship between Long Non-Coding RNA and Prognosis of Lung Cancer
    星圆 王, 2023, ACM CrossRef
  18. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer
    Jia Yee Lee et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  19. Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer
    Xiaodong Yu et al, 2024, Pharmacol. Rep CrossRef
  20. “Crosstalk between non-coding RNAs and transcription factor LRF in non-small cell lung cancer”
    Magda Spella et al, 2024, Non-coding RNA Research CrossRef
  21. microRNA 21 and long non-coding RNAs interplays underlie cancer pathophysiology: A narrative review
    Roberta Giordo et al, 2024, Non-coding RNA Research CrossRef
  22. Genetic variants of LncRNAs HOTTIP and MEG3 influence nasopharyngeal carcinoma susceptibility and clinicopathologic characteristics in the Southern Chinese population
    Xiaoxia Lao et al, 2024, Infect Agents Cancer CrossRef
  23. The therapeutic potential of RNA m(6)A in lung cancer
    Jingran Yu et al, 2024, Cell Commun Signal CrossRef